ArticleRevista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)2025
Neurocognitive and neurobiological features of early-stage, unmedicated patients with bipolar disorder.
Article in Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveThis study aimed to identify young adults who met the criteria for bipolar disorder (BD) but had not yet been diagnosed or treated. It also aimed to evaluate their neurocognitive and neurobiological changes compared to healthy controls (HC).
methodsIndividuals at high risk for BD were identified by using the Hypomania Checklist 32 items (HCL-32R). Participants were then assessed with the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) to identify previously undiagnosed and drug-naive patients (DNP) (n=27). A matched HC group (n=27) was included for comparison. All participants completed a cognitive battery assessing executive function, attention, working memory, and verbal learning. Magnetic resonance imaging (MRI) was used to assess cortical thickness. Oxidative stress markers - including thiobarbituric acid reactive substances (TBARS), nitric oxide (NO), and the antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT) - were measured.
resultsThe DNP group underperformed across all the tests administered but group differences were significant in the Wisconsin Card Sorting Test (WCST) and Rey Auditory Verbal Learning Test (RVALT). Among oxidative stress markers, only CAT levels were significantly higher in the DNP group. Additionally, patients exhibited significant cortical thinning in several brain regions.
conclusionNeurobiological alterations and neurocognitive dysfunction are present in the earlystage, unmedicated stages of BD. However, longitudinal studies are needed to better understand the progression of these changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.